Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC CCT365623 hydrochloride | 2126136-98-7 | 98.1% | 443.99 | C18H18ClNO4S3 | 25MG
Supplier: Medchemexpress LLC HY124674A25MG
CCT365623 hydrochloride is an orally active lysyl oxidase (LOX) inhibitor intended for preclinical research. It suppresses EGFR (pY1068) and AKT phosphorylation driven by EGF, has an IC50 of 0.89 μM, and is reported to have good tolerability and pharmacokinetic properties.
- Orally active lysyl oxidase inhibitor.
- IC50 about 0.89 μM in biochemical assays.
- Suppresses EGFR and AKT phosphorylation driven by EGF.
- Reported good tolerability and pharmacokinetic properties in preclinical studies.
- High chemical purity suitable for research applications.
- Available as a 25 mg research package.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?